{"entity":{"type":"insider","cik":"0001610064","url":"/insider/0001610064","json_url":"/insider/0001610064.json","name":"Shih Alvin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2015-06-30","last":"2025-09-15","span_basis":"filed_date"},"name_variants":[{"name":"Shih Alvin","source":"filing","n_filings":7,"first_seen":"2015-06-30","last_seen":"2025-09-15"}],"transactions":[{"id":5053784,"accession":"0001610064-25-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610064-25-000011","line_url":"/filing/0001610064-25-000011#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":7.89,"price_display":"7.89","price_state":"stated","total_value":157800.0,"total_display":"157,800.00","total_whole":"157,800","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-15","scope":"insider"},{"id":3294389,"accession":"0001209191-16-139907","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-139907","line_url":"/filing/0001209191-16-139907#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":16.2353,"price_display":"16.24","price_state":"stated","total_value":142058.875,"total_display":"142,058.88","total_whole":"142,059","shares_owned_after":158334.0,"shares_owned_after_display":"158,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-02","scope":"insider"},{"id":2737953,"accession":"0001209191-16-125331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-125331","line_url":"/filing/0001209191-16-125331#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":17.7467,"price_display":"17.75","price_state":"stated","total_value":155283.625,"total_display":"155,283.62","total_whole":"155,284","shares_owned_after":167084.0,"shares_owned_after_display":"167,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-02","scope":"insider"},{"id":2548011,"accession":"0001209191-16-104164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-104164","line_url":"/filing/0001209191-16-104164#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":14.3507,"price_display":"14.35","price_state":"stated","total_value":125568.625,"total_display":"125,568.62","total_whole":"125,569","shares_owned_after":175834.0,"shares_owned_after_display":"175,834","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-01","scope":"insider"},{"id":8752807,"accession":"0001209191-15-084554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-084554","line_url":"/filing/0001209191-15-084554#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":20.83,"price_display":"20.83","price_state":"stated","total_value":182262.5,"total_display":"182,262.50","total_whole":"182,263","shares_owned_after":184584.0,"shares_owned_after_display":"184,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-10","scope":"insider"},{"id":8084144,"accession":"0001209191-15-074926","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-074926","line_url":"/filing/0001209191-15-074926","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8750.0,"shares_display":"8,750","price_per_share":20.122614857142857,"price_display":"20.12","price_state":"stated","total_value":176072.88,"total_display":"176,072.88","total_whole":"176,073","shares_owned_after":197286.0,"shares_owned_after_display":"197,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-06","filed_date":"2015-10-08","scope":"insider","n_lines":3},{"id":8093969,"accession":"0001209191-15-057620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-057620","line_url":"/filing/0001209191-15-057620#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001610064","owner_name":"Shih Alvin","owner_display_name":"Shih Alvin","owner_url":"/insider/0001610064","role":"Officer (EVP of Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP of Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP of Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27916.0,"shares_display":"27,916","price_per_share":32.6999,"price_display":"32.70","price_state":"stated","total_value":912850.4084,"total_display":"912,850.41","total_whole":"912,850","shares_owned_after":202084.0,"shares_owned_after_display":"202,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-26","filed_date":"2015-06-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Director","n_filings":1,"first_seen":"2025-09-15","last_seen":"2025-09-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Retrophin, Inc.","url":"/issuer/0001438533","role":"Officer (EVP of Research & Development)","n_filings":6,"first_seen":"2015-06-30","last_seen":"2016-09-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001610064","retrieved_at":"2026-08-24T21:19:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}